---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-24-000082"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:24:02.778632+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Clover Health resolves derivative suits; $2.5M counsel fees, governance changes

## Summary
- Settlement requires no monetary payment to shareholders; $2.5M in fees to plaintiffs' counsel subject to court approval.
- Company must implement corporate governance enhancements as part of settlement.
- Court preliminarily approved settlement on March 5, 2024; final approval hearing set for July 11, 2024.
- Derivative actions stemmed from Hindenburg Research allegations and 2021 de-SPAC merger.

## SEC filing metadata
- accession: 0001801170-24-000082
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000082/0001801170-24-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000082/clov-20240404.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-24-000082
- JSON: https://secwatch.observer/filing/0001801170-24-000082.json
- Plain text: https://secwatch.observer/filing/0001801170-24-000082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.